CD8A and metabolic dysfunction-associated steatotic liver disease: It should be noted that the Hep55.1c-Tet3G-LucOS tumor is highly immunogenic, but we are still able to observe impaired CD8+ T cell anti-tumor immunity, which highlights the strong impact of NAFLD on adaptive anti-tumor immunity.